[Possibilities and limitations of uterine contraction inhibiting agents].
D000262:Adenylyl Cyclases / Q000378:metabolism; D000318:Adrenergic beta-Agonists / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D002415:Cats; D000242:Cyclic AMP / Q000378:metabolism; D005260:Female; D005333:Fetus / Q000187:drug effects; D000882:Haplorhini; D006321:Heart / Q000187:drug effects; D006801:Humans; D008099:Liver / Q000187:drug effects; D007752:Obstetric Labor, Premature / Q000188:drug therapy; D011247:Pregnancy; D011248:Pregnancy Complications; D011817:Rabbits; D051381:Rats; D012756:Sheep; D014590:Uterine Contraction / Q000187:drug effects*
D000318:Adrenergic beta-Agonists; D000242:Cyclic AMP; D000262:Adenylyl Cyclases
Mogelijkheden en beperkingen van weeënremmende middelen]